Management

show all hide all

Ivan Trifunovich PhD

Executive Chairman, President and Chief Executive Officer

Dr. Trifunovich joined the Helicos Board of Directors as Executive Chairman in September 2010 and was appointed President and Chief Executive Officer in October 2010. He has a proven track record of driving global profitable growth through focused product development and commercialization. Since 2008, Dr. Trifunovich has served as a strategic consultant to global companies in the life sciences industry. Previously, Dr. Trifunovich served as the Senior Vice President of Third Wave Technologies, Inc., a molecular diagnostics company. Prior to joining Third Wave Technologies, Inc., Dr. Trifunovich held successive positions as Vice President of e-Business and Vice President of Research Strategy and Operations at Pharmacia Corp. Prior to joining Pharmacia, Dr. Trifunovich was a Director of New Product Marketing at Johnson & Johnson, Inc. He began his career at Bristol-Meyers Squibb, Inc. as a bench scientist, where he held several positions of increasing responsibility.

Dr. Trifunovich holds a Ph.D. in organic chemistry from UCLA and an M.B.A. from the University of Pennsylvania's Wharton School of Business.

Mr. Jeffrey R. Moore

Senior Vice President and Chief Financial Officer

Mr. Moore joined Helicos in August 2009, bringing over 20 years of financial experience in life science technology and Big 4 accounting. He has a demonstrated track record of success in guiding leading edge strategic and operational initiatives that directly impact top line and bottom line results.

Previously, Mr. Moore was managing member and founder of Fiske Pond Advisors LLC, a financial advisory services firm, since 2008. Mr. Moore served as Chief Financial Officer of Affinova, Inc., a privately-held innovation technology company, from 2004 to 2008 and Vice President of Finance at Flagship Ventures from 2000 to 2006. He served as the Director of Business Analysis and Planning at Celera Genomics, the first biotechnology firm to sequence the human genome, from 1998 to 1999. Prior to Celera, Mr. Moore was Vice President of Treasury Operations at a public life science technology company, PerSeptive Biosystems.

Mr. Moore received his BS degree from Cornell University and MBA from Vanderbilt University.

Dr. Patrice M. Milos

Senior Scientific Advisor

Dr. Milos joined Helicos in June 2007. Her expertise and extensive knowledge in the life sciences advances the company's efforts to develop innovative and breakthrough technology. She previously served as Executive Director at Pfizer Global Research and Development, where she was responsible for leadership, strategic alignment and execution of the scientific disciplines of pharmacogenomics, proteomics, metabonomics and RNA profiling across the Pfizer portfolio from early discovery into the marketplace. She joined Pfizer in 1993 and held numerous research positions of increasing responsibility focusing on Cardiovascular and Metabolic Disease, Pharmacogenomics, DNA Sequencing, Biomarkers and Molecular Sciences.

Dr. Milos serves on the National Advisory Council for Human Genome Research and was pivotal in the establishment and oversight of key Pfizer strategic investments in the genomics area, most notably, the Genetic Association Information Network. She also sits on several editorial boards for journals and has published and presented extensively in the genomics area. Dr. Milos conducted post-doctoral fellowships at Brown University and Harvard University. She earned her MS and PhD degrees at Rensselear Polytechnic Institute in Troy, NY and received her BA from The College of Saint Rose in Albany, NY.